These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19754591)

  • 1. Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant.
    Goericke-Pesch S; Spang A; Schulz M; Ozalp G; Bergmann M; Ludwig C; Hoffmann B
    Reprod Domest Anim; 2009 Jul; 44 Suppl 2():302-8. PubMed ID: 19754591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant "Gonazon"; a preclinical trial.
    Ludwig C; Desmoulins PO; Driancourt MA; Goericke-Pesch S; Hoffmann B
    Theriogenology; 2009 Apr; 71(7):1037-45. PubMed ID: 19233456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of semen quality following reversible downregulation of testicular function in male dogs with a GnRH agonist implant.
    Goericke-Pesch S; Ludwig C; Hoffmann B
    Reprod Domest Anim; 2012 Aug; 47(4):625-8. PubMed ID: 22050326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restart of steroidogenesis in dogs during recrudescence of testicular function following downregulation with a GnRH-agonist implant.
    Gentil M; Hoffmann B; Spang A; Failing K; Goericke-Pesch S
    Cell Tissue Res; 2012 Dec; 350(3):513-23. PubMed ID: 23053053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog.
    Goericke-Pesch S; Wilhelm E; Ludwig C; Desmoulins PO; Driancourt MA; Hoffmann B
    Theriogenology; 2010 Apr; 73(7):920-6. PubMed ID: 20097413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible suppression of sexual activity in tomcats with deslorelin implant.
    Novotny R; Cizek P; Vitasek R; Bartoskova A; Prinosilova P; Janosovska M
    Theriogenology; 2012 Sep; 78(4):848-57. PubMed ID: 22578617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone.
    Spaliviero JA; Jimenez M; Allan CM; Handelsman DJ
    Biol Reprod; 2004 Jan; 70(1):32-8. PubMed ID: 12954730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
    Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
    Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of young rams with an agonist of GnRH delays reproductive development.
    Tilbrook AJ; Galloway DB; Williams AH; Clarke IJ
    Horm Behav; 1993 Mar; 27(1):5-28. PubMed ID: 8440517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of recombinant follicle-stimulating hormone on the restoration of spermatogenesis in the gonadotropin-releasing hormone-immunized adult rat.
    McLachlan RI; Wreford NG; de Kretser DM; Robertson DM
    Endocrinology; 1995 Sep; 136(9):4035-43. PubMed ID: 7649112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicle-stimulating hormone is required for the initial phase of spermatogenic restoration in adult rats following gonadotropin suppression.
    Meachem SJ; Wreford NG; Stanton PG; Robertson DM; McLachlan RI
    J Androl; 1998; 19(6):725-35. PubMed ID: 9876024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
    Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
    Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoprolactinemia does not prevent restoration of normal spermatogenesis in gonadotropin-suppressed, testosterone-replaced rats.
    Awoniji CA; Roberts D; Chandrashekar V; Hurst BS; Tucker KE; Schlaff WD
    J Androl; 1996; 17(1):35-40. PubMed ID: 8833739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the gonadotoxicity of Cytoxan in the dog by adjuvant treatment with a luteinizing hormone-releasing hormone agonist.
    Goodpasture JC; Bergstrom K; Vickery BH
    Cancer Res; 1988 Apr; 48(8):2174-8. PubMed ID: 2964898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of recombinant FSH on testosterone-induced spermatogenesis in gonadotrophin-deficient (hpg) mice.
    Singh J; Handelsman DJ
    J Androl; 1996; 17(4):382-93. PubMed ID: 8889701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initiation and stimulation of spermatogenesis in vitro by mammalian follicle-stimulating hormone in the Japanese newt, Cynops pyrrhogaster.
    Abé SI; Ji ZS
    Int J Dev Biol; 1994 Jun; 38(2):201-8. PubMed ID: 7981029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal and stage-specific effects of recombinant human follicle-stimulating hormone on the maintenance of spermatogenesis in gonadotropin-releasing hormone antagonist-treated rat.
    Hikim AP; Swerdloff RS
    Endocrinology; 1995 Jan; 136(1):253-61. PubMed ID: 7828538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative restoration of advanced spermatogenic cells in adult male rats made azoospermic by active immunization against luteinizing hormone or gonadotropin-releasing hormone.
    Awoniyi CA; Santulli R; Chandrashekar V; Schanbacher BD; Zirkin BR
    Endocrinology; 1989 Sep; 125(3):1303-9. PubMed ID: 2667955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterotopic transplantation as a model to study the regulation of spermatogenesis; some histomorphological considerations about sperm decline in man.
    Johnson L; Falk GU; Suggs LC; Henderson DJ; Spoede GE; Brown SW; McGowen TA; Meguerditchian H; Barnard JJ
    Contracept Fertil Sex; 1997; 25(7-8):549-55. PubMed ID: 9343904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testicular phenotype in luteinizing hormone receptor knockout animals and the effect of testosterone replacement therapy.
    Lei ZM; Mishra S; Ponnuru P; Li X; Yang ZW; Rao ChV
    Biol Reprod; 2004 Nov; 71(5):1605-13. PubMed ID: 15253923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.